National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

卷:83

Article

Gelfand, Joel M.^1,2,3  Armstrong, April W.⁴  Bell, Stacie⁵  Anesi, George L.^2,3,6  Blauvelt, Andrew⁷  Calabrese, Cassandra⁸  Dommasch, Erica D.⁹  Feldman, Steve R.¹⁰  Gladman, Dafna^11,12  Kircik, Leon^13,14  Lebwohl, Mark¹³  Lo Re, Vincent, III^2,3,15  Martin, George¹⁶  Merola, Joseph F.¹⁷  Scher, Jose U.^18,19  Schwartzman, Sergio²⁰  Treat, James R.²¹  Van Voorhees, Abby S.²²  Ellebrecht, Christoph T.¹  Fenner, Justine¹³  Ocon, Anthony²³  Syed, Maha N.¹  Weinstein, Erica J.¹⁵  Smith, Jessica⁵  Gondo, George⁵  Heydon, Sue⁵  Koons, Samantha⁵  Ritchlin, Christopher T.²³ 

[1] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA

[3] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA

[4] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90007 USA

[5] Natl Psoriasis Fdn, Portland, OR USA

[6] Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA

[7] Oregon Med Res Ctr, Portland, OR USA

[8] Cleveland Clin, Dept Rheumatol & Immunol, Cleveland, OH 44106 USA

[9] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA

[10] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC 27101 USA

[11] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada

[12] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Psoriat Arthrit Program, Toronto, ON, Canada

[13] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[14] Indiana Univ, Med Ctr, Dept Dermatol, Indianapolis, IN USA

[15] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA

[16] Dermatol Associates, Maui, HI USA

[17] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA

[18] NYU, Dept Med, Grossman Sch Med, Div Rheumatol, 550 1St Ave, New York, NY 10016 USA

[19] NYU, Langone Orthoped Hosp, New York, NY USA

[20] Hosp Special Surg, Dept Rheumatol, 535 E 70th St, New York, NY 10021 USA

[21] Childrens Hosp Philadelphia, Dept Pediat Dermatol, Philadelphia, PA 19104 USA

[22] Eastern Virginia Med Sch, Dept Dermatol, Norfolk, VA 23501 USA

[23] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA

关键词: biologics;    COVID-19;    psoriasis;    psoriatic arthritis;    SARS-CoV-2;   

DOI  :  10.1016/j.jaad.2020.09.001

来源: Elsevier

【 摘 要 】

Objective: To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. Study design: A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clinical questions relevant to the psoriatic disease community were informed by questions received by the NPF. A Delphi process was conducted. Results: The TF approved 22 guidance statements. The average of the votes was within the category of agreement for all statements. All guidance statements proposed were recommended, 9 with high consensus and 13 with moderate consensus. Limitations: The evidence behind many guidance statements is limited in quality. Conclusion: These statements provide guidance for the management of patients with psoriatic disease on topics ranging from how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what they should do if they develop COVID-19. The guidance is intended to be a living document that will be updated by the TF as data emerge.

【 授权许可】

Free